PDCD4 can combine with eukaryotic initiation factor-4A (eIF4A), thereby inhibiting its enzymatic activity, leaving the mRNA methylated decapping process unfinished and eIF4A-eIF4G complex unformed, thus inhibiting proliferation of tumor cells [18, 19]. This evidence concerns the gene PDCD4 and neoplasm.